Saratov JOURNAL of Medical and Scientific Research

"Benign" multiple sclerosis: a variant of favorable disease course and the result of effective treatment

Year: 2018, volume 14 Issue: №1 Pages: 153-156
Heading: Neurology Article type: Review
Authors: Makarov N.S., Kolokolov O.V.
Organization: Saratov State Medical University
Summary:

The article provides an overview of data on isolated demyelination syndromes that may precede multiple sclerosis, and on the peculiarities of the so-called "benign" form of multiple sclerosis. Clinical and anamnestic criteria for establishing the fact of a "benign" form of multiple sclerosis are presented, as well as trends in the number of these patients in the general population of patients with multiple sclerosis, including in connection with the improvement of treatment methods for this disease.

Bibliography:
1. Luzzio С. Multiple Sclerosis. Updated: Oct 26, 2017 https://emedicine.medscape.eom/article/1 1461 99-overview
2. Gusev El, Zavalishin IA, Boiko AN. Multiple Sclerosis. Moscow: Real Time, 2011; 528 p.
3. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology 2018; 17 (2): 162-73
4. Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis. The 2013 revisions. Neurology 2014; 83 (3): 278-286. DOI: 10.1212/WNL.0000000000000560
5. Gabelic T, Radmilovic M, Posavec V, et al. Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome. Acta Neurol 2013; 113(1); 13-7
6. Gabelic T, Ramasamy DP, Weinstock-Guttman Bet, al. Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis. AJNR Am J Neuroradiol 2014; 35 (1): 106-12
7. Okuda DT, Mowry EM, BeheshtianA, etal. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009; 72 (9): 800-5
8. Lebrun C, Bensa C, Debouverie M, et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol 2009; 66 (7): 841-6
9. Okuda DT, Siva A, Kantarci O, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE 2014;9(3):e90509
10. Amato MP, Hakiki B, Goretti B, et al. Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology 2012; 78 (5): 309-14
11 Tejeda-Velarde A, Costa-Frossard L, de la Maza SS, et al. Clinical usefulness of prognostic biomarkers in optic neuritis. Eur J Neurol 2017 DOI: 10.1111/ene.13553
12. Reynders T, D'haeseleer M, De Keyser J, et al. Definition, prevalence and predictive factors of benign multiple sclerosis. e-Neurological Science 2017; 7: 37-43
13. Pagani E, Mesaros S, Rovaris M, Caputo D, et al. Structural MRI correlates of benign multiple sclerosis. Avoxel-based morphometry study of regional grey matter atrophy. Proc Intl Soc Magn Reson Med 2008; 16: 3441
14. Filippi M, Campi A, Mammi S, Martinelli V, et al. Brain magnetic resonance imaging and multimodale voked potentials in benign and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1995; 58: 31-7 https://doi.org/10.1136/ jnnp.58.1.31
15. Ton AM, Vasconcelos CC, Alvarenga RM. Benign multiple sclerosis: aspects of cognition and neuroimaging. Arq Neuro-Psiquiatr 2017; 75 (6): 394-401. DOI: 10.1590/0004-282X20170043
16. Costelloe L, Thompson A, Walsh C, Tubridy N, et al. Longterm clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. J Neurol Neurosurg Psychiatry 2008; 79 (11): 1245-8. https://doi.org/10.1136/ jnnp.2008.143586
17. Leray E, CoustansM, Le Page E,etal. Clinically definite benign multiple sclerosis, an unwarrantedconceptual hodgepodge: evidence from a 30 year observational study. Mult Scler 2013; 19 (4): 458-65. https://doi.org/10.1177/1352458512456613
18. Hviid LE, Healy ВС, Rintell DJ, et al. Patient reported outcomes in benign multiple sclerosis. Mult Scler 2011; 17 (7): 876-84. DOI: 10.1177/1352458511398370
19. Sartori A, Abdoli M, Freedman MS. Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study. J Neurol 2017; 264 (6): 1068-75. DOI: 10.1007/ s00415-017-8487-y. Epub 2017 Apr 17
20. Zivadinov R, Cookfair DL, Krupp L, et al. Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC). ВМС Neurol 2016; 16: 102 Published online 2016 Jul 15 DOI: 10.1186/s12883-016-0623-2. PMCID: PMC4946222.

AttachmentSize
2018_01-1_153-156.pdf237.45 KB

No votes yet